EUVIMEDEUVIMED entdecken
ValidierungsstudieKohortenstudieOpen Access · CC BY 4.0

Development and Validation of Prediction Models for the Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Population‐Based Cohort Study

Lijun Chen, Linying Liu iD, Feishuang Lin, Yixin Fu, Lin Yang, Yang Sun

Cancer Medicine · 2026

DOI: 10.1002/cam4.71585 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Cancer Medicine, 2026. Verfasst von Lijun Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Nomograms, Uterine Cervical Neoplasms, Adenocarcinoma, Clear Cell. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China, Clinical Research Center for Precision Treatment of Gynecological Malignancies of Fujian Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Clear cell adenocarcinoma of the cervix (CCAC) is a rare and aggressive malignancy with poor prognosis. This study aimed to develop and validate nomograms and risk‐stratification scores for predicting overall survival (OS) and cancer‐specific survival (CSS) in CCAC patients.

Methods

Data from 429 CCAC patients were extracted from the Surveillance, Epidemiology, and End Results (SEER) database (2000–2019). Patients were randomly assigned to training and validation sets. Cox regression analysis identified five independent prognostic factors for OS and CSS, which were used to construct nomograms for predicting 1‐, 3‐, and 5‐year OS and CSS. The models were evaluated using receiver operating characteristic (AUC) analysis, calibration curves, and decision curve analysis (DCA). The clinical utility of the nomograms was compared with the 2018 FIGO Stage System using C‐index, NRI, and IDI. Patients were stratified into low‐ and high‐risk groups based on predicted risk scores, and Kaplan–Meier survival analysis was performed.

Results

Multivariate Cox regression identified age at diagnosis, tumor size, and surgery as independent prognostic factors for both OS and CSS, while chemotherapy and radiotherapy were specifically associated with OS and CSS. The C‐index for OS and CSS in the training set was 0.83 and 0.84, respectively. The AUC for 1‐, 3‐, and 5‐year OS and CSS in the training set was 0.95, 0.95, and 0.88, respectively, with similar results in the validation set. Calibration curves showed good agreement between predicted and actual outcomes. DCA, NRI, and IDI analyses indicated that the nomogram outperformed the 2018 FIGO Stage System. Survival analysis revealed that high‐risk patients had worse prognosis compared to low‐risk patients.

Conclusion

This study developed and validated nomograms for predicting OS and CSS in CCAC patients using SEER data. These models offer a more accurate prognostic tool, enhancing clinical decision‐making and enabling individualized treatment planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NomogramsUterine Cervical NeoplasmsAdenocarcinoma, Clear CellHumansFemalePrognosisSEER ProgramMiddle AgedAgedAdultKaplan-Meier EstimateNeoplasm Staging

Stichwörter der Autor:innen

SEERcancer‐specific survivalclear cell adenocarcinoma of the cervixnomogramoverall survival

Autor:innen und Institutionen

  • Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.

ORCID-Profile: Linying Liu

Förderung

  • the Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China
  • Clinical Research Center for Precision Treatment of Gynecological Malignancies of Fujian Province, China

Zitieren

APA

Chen, L., Liu, L., Lin, F., Fu, Y., Yang, L., & Sun, Y. (2026). Development and Validation of Prediction Models for the Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Population‐Based Cohort Study. Cancer Medicine. https://doi.org/10.1002/cam4.71585

Vancouver

Chen L, Liu L, Lin F, Fu Y, Yang L, Sun Y. Development and Validation of Prediction Models for the Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Population‐Based Cohort Study. Cancer Medicine. 2026. doi:10.1002/cam4.71585

BibTeX
@article{Chen2026,
  author = {Chen, Lijun and Liu, Linying and Lin, Feishuang and Fu, Yixin and Yang, Lin and Sun, Yang},
  title = {Development and Validation of Prediction Models for the Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Population‐Based Cohort Study},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71585}
}
Kostenlos starten →